Ionis Pharmaceuticals IONS Common Stock Par Value Per Share
Common Stock Par Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's common stock par value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's common stock par value per share?
- Ionis Pharmaceuticals (IONS) reported common stock par value per share of $0.00 in Q1 2026.
- How has Ionis Pharmaceuticals's common stock par value per share changed year-over-year?
- Ionis Pharmaceuticals's common stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
- What is the long-term trend for Ionis Pharmaceuticals's common stock par value per share?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's common stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.
- What does common stock par value per share mean?
- The minimum legal value assigned to each share of stock.
- How do you interpret common stock par value per share?
- Generally static; changes are rare and usually result from corporate actions like stock splits or charter amendments.
- How does common stock par value per share compare across companies?
- Often set at a nominal amount (e.g., $0.001) across most public companies.